Holen Sie sich die Stockscreener-App
47.60
5.52%
-2.78
Handel nachbörslich:
48.11
0.51
+1.07%
Schlusskurs vom Vortag:
$50.38
Offen:
$50.215
24-Stunden-Volumen:
25.99M
Relative Volume:
0.59
Marktkapitalisierung:
$10.26B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
68.99
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-8.51%
1M Leistung:
-25.88%
6M Leistung:
+59.68%
1J Leistung:
+145.11%
1-Tages-Spanne:
$47.54
$50.34
1-Wochen-Bereich:
$47.54
$53.24
52-Wochen-Spanne:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
47.60 | 11.65B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.03 | 360.50B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
59.66 | 149.48B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
86.64 | 72.01B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
22.13 | 41.89B | 15.30B | 1.06B | 1.45B | 0.55 |
|
KMB
Kimberly Clark Corp
|
126.71 | 42.29B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
History of Hims & Hers Health: Revolutionizing Personal Wellness Through Telehealth (NYSE:HIMS) - FinancialContent
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - GlobeNewswire Inc.
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - Morningstar
Securities Fraud Class Action Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Reminds Investors of August 25, 2025 - ACCESS Newswire
HIMS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS) - StreetInsider
HIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. - GlobeNewswire
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc. - FinancialContent
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Securities Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
HIMS Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Hims & Hers Health, Inc. (HIMS) - StreetInsider
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - PR Newswire
Lobbying Update: $310,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Nasdaq
How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) - Seeking Alpha
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Morningstar
Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS)Recover LossesContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
Hims & Hers health CEO Dudum sells $2.5m in shares - Investing.com Australia
HIMS Shareholder Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire
All You Need to Know About Hims & Hers Health (HIMS) Rating Upgrade to Strong Buy - Yahoo Finance
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc.August 25, 2025 Deadline - The Globe and Mail
HIMS SECURITIES FRAUD: Hims & Hers Health, Inc. (NYSE:HIMS) - GlobeNewswire
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit - Newsweek
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS) - PR Newswire
BofA Securities maintains Hims and Hers stock rating at Underperform By Investing.com - Investing.com Canada
Investors who lost money on Hims & Hers Health, Inc.(HIMS) - GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Reminds HIMS Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - The Malaysian Reserve
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” - GlobeNewswire
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? - Yahoo Finance
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025HIMS - PR Newswire
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales - USA Herald
HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy Triggers Securities Class ActionsHIMS Investors with Losses Encouraged to Contact Hagens Berman - ACCESS Newswire
Hims & Hers Brass Face Suit Over 'Knockoff' Wegovy Sales - Law360
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & - GlobeNewswire
Hims & Hers (HIMS) Faces Legal Storm Post Novo Nordisk Breakup - TipRanks
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
The Gross Law Firm Notifies Hims & Hers Health, Inc. - GlobeNewswire
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):